https://www.selleckchem.com/pr....oducts/sodium-dichlo
Compared with the status quo scenario, the elimination scenario generated $46·1 billion (35·9-53·8 billion) in cumulative productivity gains by 2030. These indirect costs made elimination cost-saving by 2027, with a net economic benefit of $22·7 billion (17·1-27·9 billion) by 2030. This model shows that countries might be underestimating the true burden of hepatitis C and will benefit from investing in elimination.In 2019, a Lancet Gastroenterology Hepatology Commission on accelerating the elimination of viral h
Like
Comment
Share
